Chemoinformaics analysis of Dehydroglyasperin C
| Molecular Weight | 354.402 | nRot | 4 |
| Heavy Atom Molecular Weight | 332.226 | nRig | 18 |
| Exact Molecular Weight | 354.147 | nRing | 3 |
| Solubility: LogS | -3.215 | nHRing | 1 |
| Solubility: LogP | 5.384 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 53.7494 |
| nHD | 3 | BPOL | 25.5426 |
| QED | 0.714 |
| Synth | 3.226 |
| Natural Product Likeliness | 2.076 |
| NR-PPAR-gamma | 0.102 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.113 |
| Pgp-sub | 0.019 |
| HIA | 0.01 |
| CACO-2 | -4.876 |
| MDCK | 0.0000184 |
| BBB | 0.016 |
| PPB | 0.947411 |
| VDSS | 0.833 |
| FU | 0.0291685 |
| CYP1A2-inh | 0.929 |
| CYP1A2-sub | 0.606 |
| CYP2c19-inh | 0.937 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.86 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.886 |
| CYP2d6-sub | 0.594 |
| CYP3a4-inh | 0.517 |
| CYP3a4-sub | 0.281 |
| CL | 12.727 |
| T12 | 0.795 |
| hERG | 0.4 |
| Ames | 0.054 |
| ROA | 0.35 |
| SkinSen | 0.926 |
| Carcinogencity | 0.159 |
| EI | 0.721 |
| Respiratory | 0.87 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.643549 |